All Stories

  1. Oman Vision 2040: A Transformative Blueprint for a Leading Healthcare System with International Standards
  2. Cost-Effectiveness Analysis of Universal Rotavirus Vaccination Schedules in Syria
  3. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  4. Aspects to Enhance in the Quality of Life of Parents of Children with Central Nervous System Tumors
  5. Mpox in the Gulf Cooperation Council Countries
  6. Influence of Culture Among Users of Illegal Drugs: An Ethnographic Study
  7. Eating Behaviors during Pregnancy: A Cross-Sectional Study
  8. Post-Traumatic Psychological Experience of COVID-19 Survivors: A Descriptive Phenomenological Study
  9. Eating Behaviors during Pregnancy: A Cross-Sectional Study
  10. Support for Mandatory COVID-19 Vaccines for Children
  11. Burden of disease scenarios for 204 countries
  12. [Review Article] Drug Use Disorder and Coping Mechanisms Due to COVID-19 Lockdown Measures: A Cross-Sectional Survey
  13. Should we be concern about the Recent Avian Influenza Outbreaks?
  14. [Review Article] Drug Use Disorder and Coping Mechanisms Due to COVID-19 Pandemic Measures: A Cross-Sectional Survey
  15. Drug Use Disorder and Coping Mechanisms Due to COVID-19 Pandemic Measures: A Cross-Sectional Survey
  16. Elimination of Mother-to-Child Transmission of Hepatitis B Virus in Gulf Cooperation Council Countries: Current Status and Future Prospects
  17. Assessing Healthcare Providers' Preparedness for Managing COVID-19 Patients: A Mixed-Methods Study
  18. Reply to Hamzavi et al. Comment on “Islam et al. Helminth Parasites among Rodents in the Middle East Countries: A Systematic Review and Meta-Analysis. Animals 2020, 10, 2342”
  19. Non-pharmaceutical Interventions (NPIs) are strategies that individuals and communities
  20. Spontaneous remission of angioimmunoblastic T‑cell lymphoma
  21. Herpes Zoster Burden of Disease and Clinical Management in Turkey: A Comprehensive Literature Review
  22. Antimicrobial Stewardship Opportunities: An Example from Oman
  23. The Progress Towards National Malaria Elimination: The Experience of Oman
  24. Forecasting smoking deaths to 2050: a forecasting analysis for the global burden of disease study
  25. This review reports on the recent epidemiology of invasive meningococcal disease (IMD) the GCC
  26. Influenza Vaccine hesitancy in EMR
  27. An outbreak of human monkeypox (Hmpox) in multiple non-endemic countries
  28. Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries
  29. Oman's COVID-19 publication trends: A cross-sectional bibliometric study
  30. The Impact of Demographic, Clinical Characteristics and the Various COVID-19 Variant Types
  31. This study aimed to assess the acceptance of COVID-19 vaccine booster doses in the countries
  32. The Role of Psychological Factors and Vaccine Conspiracy Beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 Pandemic
  33. Assessing COVID-19 Vaccine’s Acceptability Amongst Health Care Workers in Oman
  34. Alarming Antibiotic Resistance in Pediatric Oncology Patients
  35. Knowledge, Attitude, and Acceptability of COVID-19 Vaccine in Oman
  36. Improving the process of employee recognition: An exploratory study
  37. Integrated Care for the Elderly in the Primary Health Care setting Oman: The Scope and Experience
  38. Weaning Practices Impact Factors and Outcomes an experiance from Oman
  39. A Systematic Review of Influenza Epidemiology and Surveillance in the Eastern Mediterranean and North African Region
  40. Hospitalized Patients with Moderate versus Severe COVID-19 Infection
  41. Our paper illustrated the importance of influenza vaccination among DM
  42. Living-Donor Liver Transplant in Oman: A Quantitative Cross-Sectional Study of Donors’ Experiences and Challenges
  43. Epidemiological Risk Factors for Acquiring Severe COVID-19
  44. This a work done by our countries
  45. Epidemiological Characteristics of Hepatitis B Positive Patients in Oman
  46. Epidemiological Characteristics of 69,382 COVID-19 Patients in Oman
  47. An Innovative Communication Approach to Mitigate Suffering Among COVID-19 Patients and Their Families: An Experience From Oman
  48. Role of primary healthcare in the response to COVID-19
  49. Levels of Physical Activity,
  50. Community Participation Approaches for Effective National COVID-19 Pandemic Preparedness and Response: An Experience From Oman
  51. Efforts for measles elimination in the Gulf Cooperation Council countries 2015–2019: A review
  52. Helminth Parasites among Rodents in the Middle East Countries
  53. Addressing Influenza Vaccination in MENA Region during the COVID-19 Pandemic: Decreasing the Effects of the Collision
  54. Influenza Vaccination Hesitancy among Healthcare Workers in Oman
  55. Preparing the Community for an upcoming Vaccine Against COVID-19
  56. Pneumococcal Meningitis Among Children in the Post-13-Valent Pneumococcal Conjugate Vaccine Era: Three Case Reports
  57. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017
  58. COVID 19 in Oman
  59. One Health operational framework for action for the Eastern Mediterranean Region
  60. The Omani experiences in presenting the first COVID 19 cases
  61. Oman, MERS-CoV
  62. This manuscript provided information on Health promotion strategy as part of Vision 2050 in Oman
  63. This paper gives over the situation of WPV globally and specifically in Oman.
  64. Assessment of Key Performance Indicators of the Primary Health Care in Oman
  65. Zoonotic Diseases in Oman: Successes, Challenges, and Future Directions
  66. assess the impact of non-pharmaceutical interventions on the COVID-19 epidemic in Oman
  67. Hepatitis B Elimination in GHC states
  68. MERS-Cov in Oman
  69. Dengue outbreak in Oman
  70. Influenza surveillance in MENA countries
  71. EMARIS report
  72. Successes and Challenges of HIV/AIDS Program in Oman: 1984–2015
  73. TB in Oman
  74. Assessment of hepatitis B immunization programme among school students in Qatar
  75. TB Elimination in GHC states
  76. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study.
  77. Assessment of safe injection practices in health facilities in Oman
  78. Pertussis control
  79. The manuscript provided the leprosy situation in Oman and the way forward
  80. Progress towards measles, rubella and congenital rubella syndrome elimination: Oman experience
  81. Early Clinical Manifestations of CRS
  82. Late Clinical Manifestations of Congenital Rubella Syndrome
  83. Epidemiology of Pandemic H1N1 in Oman and Public Health Response, 2009
  84. Dengue epidemiological trend in Oman: a 13-year national surveillance and strategic proposition of imported cases
  85. Cost effectiveness of a pentavalent rotavirus vaccine in Oman
  86. Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman
  87. HPV epidemiological situation in EMR
  88. Progress toward Elimination of Hepatitis B Virus Transmission in Oman: Impact of Hepatitis B Vaccination
  89. Epidemiology of invasive pneumococcal infection among hospitalized children aged less than 5 years in Oman
  90. Absence of lymphatic filariasis infection among secondary-school children
  91. The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: Evidence-based approach and consensus decision-making
  92. Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study
  93. ocular manifestations of congenital rubella syndrome
  94. Poliomyelitis in Oman. I. The last outbreak?
  95. Poliomyelitis in Oman. II. Toward eradication